Indications
- xxxx
Pharmacology
- Radioimmunotherapeutic Agent, Consisting of Murine Anti-Human CD20 Monoclonal Antibody Conjugated with the Chelating Agent Tiuxetan (see Anti-CD20 Therapy, [[Anti-CD20 Therapy]]): tiuxetan chelates the radioisotopes indium-111 and yttrium-90
Administration
- xxx
Adverse Effects
Other Adverse Effects
- xxxx
References
- xxxx